Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience – Page 268

New Technique Uses Focused Sound Waves and Holograms to Control Brain Circuits

NEW YORK, Aug. 5, 2025 /PRNewswire/ — A new study provides the first visual evidence showing that brain circuits in living animals can be activated by ultrasound waves projected into specific patterns (holograms).

Led by scientists at NYU Langone Health and at the University of Zurich and ETH Zurich in Switzerland, the study describes a system that combines sources of ultrasound waves and a fiber scope connected to a camera to visualize in study mice brain targets that are directly activated by the sound. This lays the groundwork, the study authors say, for a new way to treat neurological diseases and mental health disorders from outside of the body.

Already, there are applications approved by the Food and Drug Administration and designed to reduce tremor symptoms seen in Parkinson’s disease, using intense sound waves to kill brain cells called neurons within neural pathways linked to tremors. Rather than kill neurons, the lower-intensity ultrasound waves used in the current work can temporarily activate them, the researchers say. The resulting effects can be widespread as neurons relay messages to other neurons within their circuits and between interconnected neuronal circuits.

Metabolic signals in neurons determine whether axons degrade or resist neurodegeneration, study finds

Unlike most cells in the human body, neurons—the functional cells of our nervous system—cannot typically replace themselves with healthy copies after being damaged.

Rather, after an injury from something like a stroke, concussion or neurodegenerative disease, neurons and their axons, fiber-like projections that relay , are far more likely to degrade than regenerate.

But new research from the University of Michigan opens new ways to think about neurodegeneration that could help protect patients against that degradation and neurological decline in the future.

Stem cells created from ALS patients point to potential new target for treatment

Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease, is an incurable neurological disorder affecting motor neurons—nerve cells in the brain and spinal cord that control voluntary muscle movement and breathing.

Many ALS , including those testing promising drugs, have fallen short of expectations—often because the extent of the disease can vary, and patients don’t respond the same way to medications.

But a new study led by scientists at Case Western Reserve University used created from ALS patients to target a specific gene as a kind of shut-off valve for what stresses —and it worked.

Discovery of a new analgesic promises pain relief with fewer downsides

Opioids like morphine are widely used in medical practice due to their powerful pain-relieving effects, yet they carry the risk of serious adverse effects such as respiratory depression and drug dependence. For this reason, Japan has strict regulations in place to ensure that these medications are prescribed only by authorized physicians.

In the United States, the opioid OxyContin was once frequently prescribed, triggering a surge in the misuse of synthetic opioids such as fentanyl. As a result, the number of deaths caused by surpassed 80,000 in 2023, escalating into a national public health crisis now referred to as the “opioid crisis.”

Opioids may soon have a rival, however. A team of researchers at Kyoto University has recently discovered a novel analgesic, or , that exerts its effect through an entirely different mechanism. Clinical development of their drug ADRIANA is currently underway as part of an international collaborative effort.

Imaging provides indicators for early detection of depression, paths for future prevention and treatment efforts

Novel imaging research indicates that young adults with a higher genetic risk for depression showed less brain activity in several areas when responding to rewards and punishments. The study also uncovered notable differences between men and women.

The findings from this new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, highlight potential early indicators for depression before clinical symptoms fully manifest.

Depression is one of the most common mental health conditions, and many people with depression have trouble processing rewards and punishments.

Tracing brain chemistry across humanity’s family tree

The evolutionary success of our species may have hinged on minute changes to our brain biochemistry after we diverged from the lineage leading to Neanderthals and Denisovans about half a million years ago.

Two of these tiny changes that set modern humans apart from Neanderthals and Denisovans affect the stability and genetic expression of the adenylosuccinate lyase, or ADSL. This enzyme is involved in the biosynthesis of purine, one of the fundamental building blocks of DNA, RNA, and other important biomolecules.

In a study published in PNAS, researchers from the Okinawa Institute of Science and Technology (OIST), Japan and the Max Planck Institute for Evolutionary Anthropology, Germany have discovered that these changes may play an important role in our behavior, contributing new pieces to the great puzzle of who we humans are and where we come from.

Altered protein translation elongation contributes to brain aging

The GFP gene, which has its origins in jellyfish, expresses proteins that fluoresce when illuminated with certain frequencies of light. Poeschla, of the Mayo Clinic in Rochester, Minnesota, reported his results in the journal Nature Methods.

This function is regularly used by scientists to monitor the activity of individual genes or cells in a wide variety of animals. The development and refinement of the GFP technique earned its scientific pioneers the Nobel prize for chemistry in 2008.

In the case of the glowing cats, the scientists hope to use the GM animals in the study of HIV/AIDS.

/* */